However, the study found compared to the placebo group: Participants treated with semaglutide exhibited a broad pattern of slower biological aging across epigenetic clocks linked to inflammation and blood, brain, heart, kidney, liver and metabolic health
A recent meta-analysis of 11 cardiovascular outcome trials involving 55,921 patients treated with GLP-1 RAs and 43,306 patients treated with DPP-4 inhibitors also revealed no significant association between either drug class and pancreatic cancer risk
Related Reading Glp 1 For High Blood Pressure Ozempic For High Blood Pressure Role Of Glp 1 In Blood Sugar Control And Diabetes Treatment Maximus Glp 1 Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
Huge thanks to Weight Watchers and the GLP 1 support program